(S)-2-(METHYLAMINO)-2-PHENYLACETIC ACID, 95.0%, 1g

N-(1-ethylpropyl)cycloheptanamine hydrobromide, 95.0%, 1g

tri-Lithiumcitrat Tetrahydrat, min. 99 %, reinst, 500 g, kunststoffverpackung.

Fmoc-Hyp(tBu)-OH, >96%, 1g

1H,1H,2H,2H-Nonafluorohexyl Acrylate (stabilized with TBC)>98.0%(GC)5g

Dimethylthiocarbamoyl chloride, 95.0%, 25g

(3R)-pyrrolidine-3-carboxylic acid hydrochloride, 95.0%, 10g

1-Phenylpiperidine-3-carboxamide, 95.0%, 250mg

2,6-Di(thiophen-2-yl)dithieno[3,2-b:2',3'-d]thiophene, 95+%, 50mg

tert-Butyl (2S,5S)-5-(hydroxymethyl)-2-methylpiperazine-1-carboxylate, 98%, 100mg

Methyl 1,2,3,4-tetrahydroisoquinoline-5-carboxylate hydrochloride, 95.0%, 100mg

5-Methoxypyrazolo[1,5-a]pyridine-2-carboxylic acid, 97%, 100mg

3-amino-1,7-dimethyl-1,3-dihydro-2H-indol-2-one hydrochloride, 95.0%, 5g